Legumes and the polyphenolic compounds present in them have gained a lot of interest due to their beneficial health implications. Dietary polyphenolic compounds, especially flavonoids, exert antioxidant properties and are potent inhibitors of xanthine oxidase (XO) activity. XO is the main contributor of free radicals during exercise but it is also involved in pathogenesis of several diseases such as vascular disorders, cancer and gout. In order to discover new natural, dietary XO inhibitors, some polyphenolic fractions and pure compounds isolated from two legume plant extracts were tested for their effects on XO activity. The fractions isolated from both Vicia faba and Lotus edulis plant extracts were potent inhibitors of XO with IC50 values range from 40–135 µg/mL and 55–260 µg/mL, respectively. All the pure polyphenolic compounds inhibited XO and their Ki values ranged from 13–767 µM. Ten of the compounds followed the non competitive inhibitory model whereas one of them was a competitive inhibitor. These findings indicate that flavonoid isolates from legume plant extracts are novel, natural XO inhibitors. Their mode of action is under investigation in order to examine their potential in drug design for diseases related to overwhelming XO action.
Citation: Spanou C, Veskoukis AS, Kerasioti T, Kontou M, Angelis A, Aligiannis N, et al. (2012) Flavonoid Glycosides Isolated from Unique Legume Plant Extracts as Novel Inhibitors of Xanthine Oxidase. PLoS ONE 7(3): e32214. https://doi.org/10.1371/journal.pone.0032214
Editor: Kamyar Afarinkia, University of Bradford, United Kingdom
Received: November 16, 2011; Accepted: January 25, 2012; Published: March 2, 2012
Copyright: © 2012 Spanou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: There was no specific funding for this study.
Competing interests: The authors have declared that no competing interests exist.
Xanthine oxidase (XO) is a flavoprotein, which belongs to molybdenum hydroxylase superfamily and consists of two identical subunits of 145 kDa. Each subunit of the molecule is composed of an N-terminal 20-kDa domain containing two iron-sulfur clusters, a central 40-kDa FAD-binding domain and a C-terminal 85-kDa molybdopterin-binding domain with the four redox centers aligned in an almost linear fashion. Its active form is a homodimer of 290 kDa with each of the monomers acting independently in catalysis . XO is a cytosolic enzyme present in various species, namely bacteria, higher plants, invertebrates and vertebrates . It is also present in several mammalian tissues such as liver, intestine, kidney, lungs, myocardium, brain, plasma and erythrocytes. Among them, XO activity is highest in liver and intestine .
XO is the enzyme, which participates in purine degradation, is the main contributor of free radicals during exercise , . It uses molecular oxygen as the electron acceptor thereby resulting in production of superoxide radical (O2•−) and hydrogen peroxide (H2O2) . However, XO also results in uric acid production which constitutes the most abundant antioxidant molecule in plasma. Thus, the role of XO in redox status is unequivocal since its activity leads to the production of both free radicals and uric acid. Furthermore, XO exhibits a broad specificity toward oxidation of a wide variety of heterocyclic compounds such as purines and pteridines ,  and numerous aliphatic and aromatic aldehydes to the corresponding carboxylic acid , . Therefore, it participates in the detoxification of endogenous compounds and xenobiotics.
XO is considered as a major contributor of free radicals in various pathological conditions. More specifically, XO has been implicated in several diseases including ischemia-reperfusion injury, myocardial infarction, hypertension, atherosclerosis, diabetes and cancer . As it has been previously stated XO results not only in free radical production but also in uric acid generation. Gout is a condition where excessive uric acid formation leads to its crystallization and deposition of uric acid crystals in the joints, the connective tissues and the kidneys . Thus, the inhibition of XO activity may have simultaneously antiradical and inhibitory properties with therapeutic interest. The most commonly used and well studied XO inhibitor is allopurinol , .
Allopurinol [4-hydroxypyrazolo (3,4-d) pyrimidine] is a structural analogue of hypoxanthine . It inhibits the conversion of hypoxanthine to xanthine to uric acid thus decreasing uric acid concentration. It is the only specific competitive, non natural XO inhibitor and is widely used as a drug. Moreover, due to its property to inhibit O2•− production, via XO inhibition, allopurinol is considered as a potent antioxidant . However, this is controversial because allopurinol is also considered as a prooxidant molecule because it leads to inhibition of uric acid production as well .
Recently, a lot of research has been conducted in order to discover new, natural and specific XO inhibitors . Various plant extracts ,  and polyphenolic compounds, especially flavonoids , , have been previously examined for their inhibitory properties against XO activity. Legumes constitute an important source of polyphenols including flavonoids (kaempferol, quercetin, anthocyanins and tannins), flavonoid glycosides, isoflavones, phenolic acids and lignans , .
In a previous study in our research group, several extracts derived from Leguminosae family plants cultivated in Greece have been studied for their antioxidant and chemopreventive properties . More specifically, Leguminosae family plant extracts and 14 fractions rich in polyphenolic compounds isolated from 2 of them exhibited potent antiradical and chemopreventive properties and protected DNA against free radical-induced damage , . In extending these studies, we examined the effects of some of the aforementioned extracts on XO activity. From the results obtained, the extracts exhibited potent inhibitory activity on XO implying that polyphenols present in them are responsible for their biological properties . Our previous results imply that these specific plant extracts are a possible source of new natural XO inhibitors. Thus, in the present study we examined the inhibitory activity of the 14 fractions and pure polyphenolic compounds isolated from them on XO.
Materials and Methods
There were no specific permits were required for the described field studies. In addition, no specific permissions were required for the collection of the plants, where the extracts were obtained. This is because the studied legume plants are very common in Greece and they are not cultivated in privately-owned or protected areas. Finally, the field studies did not involve endangered or protected species.
Chemicals and reagents
Xanthine oxidase from bovine milk and allopurinol were purchased from Sigma-Aldrich (St Louis MO, USA). All the other chemicals, KH2PO4, Na2HPO42H2O and EDTA, were purchased from Sigma-Aldrich (St Louis MO, USA) and were of the highest quality (≥99.0%) commercially available.
The edible plants V. faba and L. edulis (Leguminosae) were cultivated in a parcel near to village ‘Zaros’ of the island Crete (Greece). After harvesting (2005), the aerial parts of the plants (leaves and branches) were transferred to the laboratory and left to dry under shadow at room temperature. The air-dried aerial plant parts were pulverized by a mill machine (Allenwest, Brighton, England).
Extraction, fractionation and identification of polyphenolic isolates
The extraction, fractionation and identification of the polyphenolic fractions has been previously described . Thin-layer chromatography (TLC) was carried out on glass pre-coated silica gel 60 F254 plates (Merck). Fast centrifugal partition chromatography (FCPC) was performed using a CPC KROMATON with a 1000 mL column, adjustable rotation of 200–2000 rpm and a Lab Alliance pump with a pressure safety limit of 50 bars. A manual sample injection valve was used to introduce the samples into the column. A Τhermo Finnigan HPLC instrument was employed making use of a SpectraSystem P4000 pump, SpectraSystem 1000 degasser, SpectraSystem AS3000 automated injector and a UV SpectralSystem UV2000 detector. NMR spectra were obtained with a Bruker AC200 (200 MHz) and a Bruker DRX 400 (400 MHz) spectrometer. Chemical shifts were given as δ values with TMS as the internal standard. The 2-D experiments (COSY, COSY LR, HMQC, HMBC, TOCSY and NOESY) were performed using standard Brucker micro programs. ESMS (Electron Spray Mass Spectrometry) were recorded with a Nermag R 10 10 C apparatus.
In details, the powder of the aerial parts of V. faba (0.890 Kg) and L. edulis (0.490 Kg) were extracted with CH2Cl2 (dichloromethane), MeOH (methanol) and H2O (water), successively. Each solvent extraction (3×5 L) was repeated three times, for 48 h per extraction. The MeOH extract of V. faba (48.1 g) was processed with resin XAD-4 in purpose to separate the total of phenolic compounds (12.4 g). A part of this fraction (12 g) was subjected to CPC separation using a mixture of EtOAc∶ n-BuOH∶ H2O (2∶1∶3) as biphasic system. The separation was run at a revolution speed of 1000 rpm. Initially, the lower phase was used as the mobile phase (water based), while the upper phase was used as the stationary phase in a head to tail or descending mode (flow rate 15 mL/min). The effluent of the column was manually collected in 30 mL aliquots and this procedure resulted in eleven fractions (Vf A–L). Then, the organic layer in a tail to head or ascending mode and five fractions (Vf M–Q) were collected.
Similarly, a part of the L. edulis MeOH extract (12 g) was subjected to CPC separation using a mixture of heptane∶ EtOAc∶ MeOH∶ H2O (1∶4∶1∶4) as biphasic system. The separation was run at a revolution speed of 1100 rpm. Initially, the upper layer of the biphasic system was used as the mobile phase, while the lower layer (water based) was used as the stationary phase in a tail to head or ascending mode (flow rate 15 mL/min). The effluent of the column was manually collected in 30 mL aliquots and this procedure resulted in nine fractions (Le A–I). Then, the water layer was used as mobile phase in a head to tail or descending mode and six fractions (Le K–P) were collected.
All fractions isolated from both plants, were examined by thin layer chromatography (TLC) and analytical high performance liquid chromatography (HPLC) using a 250×4.0 mm i.d Lichrosorb RP18 column (BIRSHOFF Chromatography, Loenberg, Germany). The mobile phase was a linear gradient of 2% aqueous acetic acid (solvent A) and acetonitrile (solvent B). Conditions: initial A–B (95∶5); in 70 min A–B (75∶25); back to initial conditions; flow rate 1 mL/min. Further purification of compounds of interest was accomplished using preparative HPLC. All compounds were structurally elucidated using 1D and 2D NMR spectroscopy as well as UV and MS techniques (Fig. 1). All the known compounds (1–11) were confirmed by comparison to literature data –. Compounds 12 and 13 were new and their characterization was described in a previous study of ours .
Fractions and pure polyphenolic compounds
Ten fractions were isolated from the aerial parts extract of V. faba and four from the extract of L. edulis (Table 1). Fourteen polyphenolic compounds were identified in the fractions and apart from compound 3 they are kaempferol and quercetin glycosides. The structure of the compounds that constitute each fraction is depicted in Fig. 1 and classified according to the basic flavonoid structure. More specifically the compounds identified are: Compound 1: Quercetin 3-O-[α-L-rhamnopyranosyl(1→2)-β-D-galactopyranosyl]-7-O-α-L-rhamnopyranoside; Compound 2: Quercetin 3-O[α-L-rhamnopyranosyl(1→2)-β-D-glucopyranosyl]-7-O-α-L-rhamnopyranoside; Compound 3: (6S,9R)-Roseoside; Compound 4 (a,b isomers): Kaempferol 3-O-[α-L-rhamnopyranosyl(1→2)-β-D-glucopyranosyl]-7-O-α-L-rhamnopyranoside and Kaempferol 3-O-[α-L-rhamnopyranosyl(1→2)-β-D-galactopyranosyl]-7-O-α-L-rhamnopyranoside; Compound 5: 5: Kaempferol 3-O-β-D-galactopyranosyl-7-O-α-L-rhamnopyranoside; Compound 6: Quercetin 3-O-[α-L-rhamnopyranosyl(1→2)-6-O-acetyl-β-D-galactopyranosyl]-7-O-α-L-rhamnopyranoside; Compound 7: Kaempferol 3-O-α-L-rhamnopyranosyl-7-O-α-L-rhamnopyranoside; Compound 8: Kaempferol 3-O-(6-O-β-D-acetylglucopyranosyl)-7-O-α-L-rhamnopyranoside; Compound 9: Kaempferol 3-O-α-L-arabinopyranosyl-7-O-α-L-rhamnopyranoside; Compound 10: Kaempferol 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside; Compound 11a: Kaempferol 3-O-(3-O-acetyl-α-L-rhamnopyranosyl)-7-O-α-L-rhamnopyranoside; Compound 11b: Kaempferol 3-O-(2-O-acetyl-α-L-rhamnopyranosyl)-7-O-α-L-rhamnopyranoside; Compound 12: Kaempferol 3-O-β-D-apiofuranosyl-7-O-α-L-rhamnopyranoside; Compound 13: Kaempferol 3-O-(5-O-acetyl-β-D-apiofuranosyl)-7-O-α-L-rhamnopyranoside.
The composition of the fractions with the aforementioned compounds is presented in Table 1. Only fraction Vf L is consisted of unidentified non polar compounds. On the contrary with V. faba fractions, which were consisted of a combination of phenolic compounds, L. edulis fractions were mainly consisted of pure flavonoid compounds (Table 1). Only Le E fraction was consisted of a mixture of two isomers of compound 11, 11a and 11b (Table 1).
Assessment of XO activity
XO activity was determined by measuring the formation of uric acid from xanthine within a set time. Changes in the levels of uric acid produced through the presence of the test samples allow the potency of inhibitors to be assessed. Initially the effect of the polyphenolic fractions and compounds on the inhibition of enzymatic activity was assessed at substrate concentration where maximum velocity was obtained. All initial reaction rates were in the linear scale and were measured over the first 4 min of the reaction. Each assay was performed in triplicates and the optical density was measured using a Hitachi U-1500 Spectrophotometer (San Jose, USA). The reaction mixture (500 µL) contained sodium phosphate buffer (33 mM pH 7.5 with EDTA 0.1 mM), xanthine (4.8 µM) and the extract in various concentrations. The reaction was initiated through the addition of 43 mU unit of XO diluted in H2O. The production of uric acid was determined at room temperature at 295 nm for 4 min. Control samples were prepared identically to the test samples without the addition of the specimen.
The IC50 values were determined as the concentration of the fractions or compounds required to inhibit XO activity by 50% monitored through the decrease in uric acid production. Allopurinol was used as positive control since it is a known inhibitor of XO . The measured absorbance was corrected for the contribution of the tested fractions and the pure polyphenolic compounds.
Statistical computations were carried out using SPSS 13.0 software. For statistical analysis, one-way ANOVA was applied followed by Dunnett's test for multiple pair-wise comparisons. Differences were considered significant at p<0.05. The steady state kinetic parameters (Km and Vmax) were determined (under standard assays conditions) by analyzing formation of uric acid from xanthine under initial rate conditions using the Lineweaver-Burk linearization of the Micaelis-Menten equation. The Ki values and the apparent kinetic parameters Km and Vmax were analyzed with the statistic package Grafit 6 (Erithacus Software, Ltd., Horley, UK).
Inhibitory activity of the polyphenolic fractions
All the fractions isolated form both V. faba and L. edulis plant extracts were potent inhibitors of XO. IC50 values range from 40–135 µg/mL and 55–260 µg/mL for V. faba and L. edulis fractions, respectively (Table 1). All the polyphenolic fractions showed higher XO inhibition than that of the initial plant extracts (Table 1). According to the results of V. faba fractions, Vf N exerted the most potent inhibitory activity on XO whereas Vf B was the less potent. Regarding L. edulis, Le E and Le N were the most and the less potent fractions, respectively.
Inhibitory activity of the pure polyphenolic compounds
From the 14 identified compounds only 11 were tested for their inhibitory activity on XO (Table 2). More specifically, the compounds 6 and 8 were not isolated because they were detected in very low quantities in the fractions (Fig. 1). Additionally, the compounds 11a and 11b could not be separated from the fraction Le E (Table 1, Fig. 1).
All the pure polyphenolic compounds inhibited XO (Table 2). The Ki values range from 13–767 µM. According to the kinetic analysis compound 13 was the only competitive and the most potent inhibitor (Fig. 2). The remaining 10 compounds followed the non competitive inhibitory model (Table 2). Compound 4b was the most potent among them (Table 2) and compound 3 the less potent. Additionally, all the compounds were less potent inhibitors than allopurinol (Table 2).
Legumes have recently gained a lot of interest for the beneficial health implications of their polyphenolic compounds , . Dietary polyphenolic compounds, especially flavonoids, except their potent antioxidant activity ,  they are potent inhibitors of XO activity , . XO is the main contributor of free radicals during exercise but it is also involved in pathogenesis of several diseases such as vascular disorders, cancer and gout , , . In order to discover new natural, dietary XO inhibitors, some polyphenolic fractions and pure compounds isolated from two legume plant extracts were tested for their effects on XO activity.
The two methanolic extracts, where the fractions and the polyphenolic compounds are originated from, exhibited potent XO inhibitory activity (Table 1). From the results obtained, all the polyphenolic fractions were more potent than the initial total extracts. The different combinations of polyphenolic compounds present in each fraction could partly explain the different inhibitory efficiency of the fractions (Table 1). The most potent activity of the isolates also implies that the polyphenolic compounds may act differently when they are present in an extract. For example, Vf N which was the most potent polyphenolic fraction had IC50 value at 40 µg/mL, whereas the initial V. faba plant extract had IC50 value at 540 µg/mL. Additionally, their enrichment in the procedure of their final preparation may be another reason for their high activity as compared to their initial fractions.
All the pure polyphenolic compounds inhibited XO and the Ki values range from 13 to767 µM (Table 2). Their IC50 values, range from 42 to 260 µg/mL implying that the pure compounds exert the same pattern of action either they are pure or as a mixture in a fraction (Table 1). A representative example is the fraction Vf P which is consisted of the compounds 9 and 10 in the same ratio (1∶1). The IC50 values of the compounds 9 and 10 are 63 and 42 µg/mL respectively whereas the IC50 of the Vf P fraction is 55 µg/mL, demonstrating that there is not a synergistic effect of the two compounds.
It is noteworthy that all potent compounds were flavonol glycosides and more specifically kaempferol and quercetin glycosides. Various flavonoids are known for their inhibitory activity on XO. Regarding the basic chemical structure of flavonols, the hydroxyl groups at C5 and C7 along with the double bond between C2 and C3 were found to be essential for their high inhibitory activity , . The compounds tested in the present study have the double bond between C2 and C3 and the unsubstituted hydroxyl group at C5, whereas the hydroxyl groups at C7 and C3 are substituted with the glycosides (Fig. 1). Consequently, the observed inhibitory activity is partly attributed to these characteristics. However, quercetin and kaempferol, the aglycone forms of our compounds, exhibit very low Ki values in comparison with our results . Previous studies have demonstrated that the substitution of hydroxyl groups at C7 and C3 of the basic flavonoid structure by a glycoside or a methyl group seems to decrease the XO inhibitory effect . Therefore, the presence of the glycosides is responsible for the lower inhibitory activity of our compounds.
According to the kinetic analysis, compound 13 was the only competitive and the most potent inhibitor (Fig. 2). The compound 3 which is a non flavonoid had the less potent inhibitory activity (Fig. 1). It is noteworthy that compound 13 differs from compound 12 in one acetyl group (-COCH3) at its chemical structure. Unexpectedly such a small structural difference may result in the different competition scheme (Table 2) (Fig. 1,2). Similarly, these compounds exhibited different antioxidant and chemopreventive properties (21). Additionally, it is noteworthy despite the fact that compounds 4a and 4b constitute isomers of the same compound they exhibited different potency at their inhibitory action (Table 2). It seems that the inhibitory activity of the compounds depends on the position of the hydroxyl group (4a equatorial, 4b axial) at the glycoside substituting the hydroxyl group C3 of the basic flavonoid structure (Fig. 1). Furthermore, compounds 1, 2, 9 and 10 were potent non competitive inhibitors. Despite the fact that quercetin glycosides 1 and 2 and kaempferol glycosides 9 and 10 have structure differences in their C3-O-glycoside, they exert similar activities (Table 2, Fig. 1).
In order to elucidate the specific mechanism of inhibition and justify the aforementioned differences, more detailed kinetic analysis and structural work is in progress in order to find the mode of binding of these compounds to the enzyme molecule, since the crystal structure of XO from bovine milk has been previously elucidated , . As yet, reports concerning the mode of inhibition of polyphenolic compounds have been contradictory .
As mentioned above, allopurinol was used as a positive marker of potent XO inhibitory activity. Indeed, its Ki value was about 10 to 1000 fold lower than the Ki values of the tested polyphenolic compounds (Table 2). This is due to the fact that allopurinol is a structural isomer of xanthine and a specific competitive inhibitor of XO. The polyphenolic compounds tested are novel, natural XO inhibitors. However the findings of this study serve as preliminary data for further modifications in the structure of the compounds. When the mechanism of XO inhibition is fully explained, there is possibility that some of these molecules may serve as lead compounds with better and more specific inhibitory properties for drug design. These molecules are natural products that possibly lack the side effects of allopurinol .
The pleiotropic action of the polyphenolic fractions isolated from the legume extracts have been previously investigated and assessed . More specifically, they possess potent antioxidant and chemopreventive properties against free radical-induced DNA damage . Generally, polyphenols have been established as pleiotropic molecules with various biological properties . Furthermore, XO inhibition is mainly considered as a mechanism of the antioxidant activity of polyphenols as the majority of the studies consider XO as a contributor of free radicals , . Thus, these flavonoid isolates and the initial extracts and fractions may be used as antioxidant, nutritional supplements.
Antioxidants and polyphenolic compounds have been widely used as part of human daily diet or as supplements especially before exercise in order to provide protection against exercise-induced oxidative stress or tissue oxidative damage. However, XO inhibition leads not only to decrease of free radical production but also to inhibition of uric acid generation. When oxidative stress is present, uric acid is necessary as potent antioxidant molecule. It is not well established if inhibition of free radical production or uric acid generation is more useful during exercise. Recent evidence of our research group have demonstrated that allopurinol administration, a known antioxidant molecule and XO inhibitor, induced oxidative stress and reduced performance after swimming until exhaustion in rats . In this case, uric acid seems to be essential for ameliorating the harmful effects of exercise.
The findings of this study indicate that flavonoid isolates from fractions derived from legume plant extracts are novel, natural XO inhibitors. Their mode of action is under investigation in order examine their potential in drug design for XO related diseases such as gout. Considering that legumes have beneficial health implications, they may be used as dietary supplements. Nevertheless, regarding that XO inhibition seems to favour oxidative stress their supplementation before exercise should be carefully considered.
This study was conducted during the postgraduate program “Molecular Biology and Genetics Applications - Diagnostic Markers” in the Department of Biochemistry and Biotechnology of University of Thessaly.
Conceived and designed the experiments: DK. Performed the experiments: TK. Analyzed the data: CS ASV MK. Contributed reagents/materials/analysis tools: AA NA A-LS DK. Wrote the paper: CS ASV DK.
- 1. Borges F, Fernandes E, Roleira F (2002) Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 9: 195–217.F. BorgesE. FernandesF. Roleira2002Progress towards the discovery of xanthine oxidase inhibitors.Curr Med Chem9195217
- 2. Woolfolk CA, Downard JS (1977) Distribution of xanthine oxidase and xanthine dehydrogenase specificity types among bacteria. J Bacteriol 130: 1175.CA WoolfolkJS Downard1977Distribution of xanthine oxidase and xanthine dehydrogenase specificity types among bacteria.J Bacteriol1301175
- 3. Krenitsky TA, Spector T, Hall WW (1986) Xanthine oxidase from human liver: purification and characterization. Arch Biochem Biophys 247: 108–119.TA KrenitskyT. SpectorWW Hall1986Xanthine oxidase from human liver: purification and characterization.Arch Biochem Biophys247108119
- 4. McCord JM, Fridovich I (1968) The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem 243: 5753–5760.JM McCordI. Fridovich1968The reduction of cytochrome c by milk xanthine oxidase.J Biol Chem24357535760
- 5. Gomez-Cabrera MC, Borras C, Pallardo FV, Sastre J, Ji LL, Vina J (2005) Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats. J Physiol 567: 113–120.MC Gomez-CabreraC. BorrasFV PallardoJ. SastreLL JiJ. Vina2005Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats.J Physiol567113120
- 6. Beedham C, Critchley DJ, Rance DJ (1995) Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon. Arch Biochem Biophys 319: 481–90.C. BeedhamDJ CritchleyDJ Rance1995Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.Arch Biochem Biophys31948190
- 7. Panoutsopoulos GI, Beedham C (2004) Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin. Acta Biochim Pol 51: 943–51.GI PanoutsopoulosC. Beedham2004Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.Acta Biochim Pol5194351
- 8. Panoutsopoulos GI, Kouretas D, Beedham C (2004) Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes. Chem Res Toxicol 17: 1368–76.GI PanoutsopoulosD. KouretasC. Beedham2004Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes.Chem Res Toxicol17136876
- 9. Veskoukis AS, Kouretas D, Panoutsopoulos GI (2006) Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for methyl- and nitrobenzaldehydes. Eur J Drug Metab Pharmacokinet 31: 11–16.AS VeskoukisD. KouretasGI Panoutsopoulos2006Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for methyl- and nitrobenzaldehydes.Eur J Drug Metab Pharmacokinet311116
- 10. Halliwell B (1996) “Uric acid: an example of antioxidant evaluation”. In: Cadenas E, Packer L, editors. Handbook of Antioxidants New York: Marcel Dekker: Inc. B. Halliwell1996“Uric acid: an example of antioxidant evaluation”E. CadenasL. PackerHandbook of Antioxidants New YorkMarcel Dekker: Inc
- 11. Pacher P, Nivorozhkin A, Szabó C (2006) Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58: 87–114.P. PacherA. NivorozhkinC. Szabó2006Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.Pharmacol Rev5887114
- 12. Kelley WN, Beardmore TD (1970) Allopurinol: alteration in pyrimidine metabolism in man. Science 169: 388–390.WN KelleyTD Beardmore1970Allopurinol: alteration in pyrimidine metabolism in man.Science169388390
- 13. Parks DA, Granger DN (1986) Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand Suppl 548: 87–99.DA ParksDN Granger1986Xanthine oxidase: biochemistry, distribution and physiology.Acta Physiol Scand Suppl5488799
- 14. Veskoukis AS, Nikolaidis MG, Kyparos A, Kokkinos D, Nepka C, et al. (2008) Effects of xanthine oxidase inhibition on oxidative stress and swimming performance in rats. Appl Physiol Nutr Metab 33: 1140–1154.AS VeskoukisMG NikolaidisA. KyparosD. KokkinosC. Nepka2008Effects of xanthine oxidase inhibition on oxidative stress and swimming performance in rats.Appl Physiol Nutr Metab3311401154
- 15. Dew TP, Day AJ, Morgan MR (2005) Xanthine oxidase activity in vitro: effects of food extracts and components. J Agric Food Chem 53: 6510–6515.TP DewAJ DayMR Morgan2005Xanthine oxidase activity in vitro: effects of food extracts and components.J Agric Food Chem5365106515
- 16. Sweeney AP, Wyllie SG, Shalliker RA, Markham JL (2001) Xanthine oxidase inhibitory activity of selected Australian native plants. J Ethnopharmacol 75: 273–277.AP SweeneySG WyllieRA ShallikerJL Markham2001Xanthine oxidase inhibitory activity of selected Australian native plants.J Ethnopharmacol75273277
- 17. Cos P, Ying L, Calomme M, Hu JP, Cimanga K, et al. (1998) Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 61: 71–76.P. CosL. YingM. CalommeJP HuK. Cimanga1998Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.J Nat Prod617176
- 18. Nagao A, Seki M, Kobayashi H (1999) Inhibition of xanthine oxidase by flavonoids. Biosc Biotech Biochem 63: 1787–1790.A. NagaoM. SekiH. Kobayashi1999Inhibition of xanthine oxidase by flavonoids.Biosc Biotech Biochem6317871790
- 19. Campos-Vega R, Loarca-Piña G, Oomah BD (2010) Minor components of pulses and their potential impact on human health. Food Res Intern 43: 461–482.R. Campos-VegaG. Loarca-PiñaBD Oomah2010Minor components of pulses and their potential impact on human health.Food Res Intern43461482
- 20. Rochfort S, Panozzo J (2007) Phytochemicals for health, the role of pulses. J Agric Food Chem 55: 7981–7994.S. RochfortJ. Panozzo2007Phytochemicals for health, the role of pulses.J Agric Food Chem5579817994
- 21. Spanou C, Stagos D, Tousias L, Angelis A, Aligiannis N, et al. (2007) Assessment of antioxidant activity of extracts from unique Greek varieties of Leguminosae plants using in vitro assays. Anticancer Res 27: 3403–3410.C. SpanouD. StagosL. TousiasA. AngelisN. Aligiannis2007Assessment of antioxidant activity of extracts from unique Greek varieties of Leguminosae plants using in vitro assays.Anticancer Res2734033410
- 22. Spanou C, Bourou G, Dervishi A, Aligiannis N, Angelis A, et al. (2008) Antioxidant and chemopreventive properties of polyphenolic compounds derived from Greek legume plant extracts. J Agric Food Chem 56: 6967–6976.C. SpanouG. BourouA. DervishiN. AligiannisA. Angelis2008Antioxidant and chemopreventive properties of polyphenolic compounds derived from Greek legume plant extracts.J Agric Food Chem5669676976
- 23. Spanou CI, Veskoukis AS, Stagos D, Liadaki K, Aligiannis N, et al. (2011) Effects of greek legume plant extracts on xanthine oxidase, catalase and superoxide dismutase activities. J Physiol Biochem. CI SpanouAS VeskoukisD. StagosK. LiadakiN. Aligiannis2011Effects of greek legume plant extracts on xanthine oxidase, catalase and superoxide dismutase activities.J Physiol Biochem(in press). (in press).
- 24. Huang S, Huang Q, Yi X, Huang L, Yu J (2007) Chemical constituents in leaves of Litchi chinensis. Sonn Zhongcaoyao 38: 1313–1315.S. HuangQ. HuangX. YiL. HuangJ. Yu2007Chemical constituents in leaves of Litchi chinensis.Sonn Zhongcaoyao3813131315
- 25. Mulinacci N, Vincieri FF, Baldi A, Bambagiotti-Alberti M, Sendlt A, et al. (1995) Flavonol glycosides from Sedum Telephium subspecies maximum leaves. Phytochem 38: 531–533.N. MulinacciFF VincieriA. BaldiM. Bambagiotti-AlbertiA. Sendlt1995Flavonol glycosides from Sedum Telephium subspecies maximum leaves.Phytochem38531533
- 26. Yoshimitsu H, Nishida M, Hashimoto F, Tanaka M, Sakata Y, et al. (2007) Chromone and flavonol glycosides from Delphinium hybridum cv.“Belladonna Casablanca”. J Nat Med 61: 334–338.H. YoshimitsuM. NishidaF. HashimotoM. TanakaY. Sakata2007Chromone and flavonol glycosides from Delphinium hybridum cv.“Belladonna Casablanca”.J Nat Med61334338
- 27. Yumiko Y, Masayoshi I (2005) Synthesis of optically active vomifoliol and roseoside stereoisomers. Chem Pharm Bull 53: 541–546.Y. YumikoI. Masayoshi2005Synthesis of optically active vomifoliol and roseoside stereoisomers.Chem Pharm Bull53541546
- 28. Takeda Y, Zhang H, Masuda T, Honda G, Otsuka H, et al. (1997) Megastigmane glucosides from Stachys byzantina. Phytochem 44: 1335–1337.Y. TakedaH. ZhangT. MasudaG. HondaH. Otsuka1997Megastigmane glucosides from Stachys byzantina.Phytochem4413351337
- 29. Wang W, Li XC, Ali Z, Khan IA (2009) Two new C(13) nor-isoprenoids from the leaves of Casearia sylvestris. Chem Pharm Bull 57: 636–638.W. WangXC LiZ. AliIA Khan2009Two new C(13) nor-isoprenoids from the leaves of Casearia sylvestris.Chem Pharm Bull57636638
- 30. Shen Y, Terazawa M (2001) Dihydroroseoside, a new cyclohexanone glucoside, from the leaves of shirakamba (Betula platyphylla Sukatchev var. japonica Hara). J Wood Sci 47: 145–148.Y. ShenM. Terazawa2001Dihydroroseoside, a new cyclohexanone glucoside, from the leaves of shirakamba (Betula platyphylla Sukatchev var. japonica Hara).J Wood Sci47145148
- 31. Tom-Lorente F, Garcia-Grau MM, Tom-Barberan FA, Nietot JL (1989) Acetylated flavonol glycosides from Vicia faba leaves. Phytochem 28: 1993–1995.F. Tom-LorenteMM Garcia-GrauFA Tom-BarberanJL Nietot1989Acetylated flavonol glycosides from Vicia faba leaves.Phytochem2819931995
- 32. Agrawal PK (1989) Carbon-13 NMR of Flavonoids. PK Agrawal1989Carbon-13 NMR of Flavonoids.Elsevier Science Publishing Co.:Amsterdam. Elsevier Science Publishing Co.:Amsterdam.
- 33. Lru Q, Lru M, Mabry TJ, Dixon RA (1994) Flavonol glycosides from Cephalocereus senzlls. Phytochem 36: 229–231.Q. LruM. LruTJ MabryRA Dixon1994Flavonol glycosides from Cephalocereus senzlls.Phytochem36229231
- 34. Takaya Y, Kondo Y, Furukawa T, Niwa M (2003) Antioxidant constituents of radish sprout (Kaiware-daikon), Raphanus sativus L.. J Agric Food Chem 51: 8061–8066.Y. TakayaY. KondoT. FurukawaM. Niwa2003Antioxidant constituents of radish sprout (Kaiware-daikon), Raphanus sativus L..J Agric Food Chem5180618066
- 35. Ozden Se, Burust N, Toki K, Saito N, Honda T (1989) Acetylate kaempferol glycosides from the flowers of Delfinium formosusm. Phytochem 49: 241–245.Se OzdenN. BurustK. TokiN. SaitoT. Honda1989Acetylate kaempferol glycosides from the flowers of Delfinium formosusm.Phytochem49241245
- 36. Nakano K, Takatani M, Tomimatsu T, Nohara T (1983) Four kaempferol glycosides from leaves of Cinnamomum sieboldii. Phytochem 22: 2831–2833.K. NakanoM. TakataniT. TomimatsuT. Nohara1983Four kaempferol glycosides from leaves of Cinnamomum sieboldii.Phytochem2228312833
- 37. Hasan A, Ahmad I, Ajab Khant M, Iqbal Chudhary M (1996) Two flavonol triglycosides from flowers of Indigofera hebepetala. Phytochem 43: 1115–1118.A. HasanI. AhmadM. Ajab KhantM. Iqbal Chudhary1996Two flavonol triglycosides from flowers of Indigofera hebepetala.Phytochem4311151118
- 38. Perez-Castorena Ana-L, Castro A, deVivar AR (1997) A dirhamnopyranoside from Psacalium megaphyllum. Phytochem 46: 1297–1300.Ana-L Perez-CastorenaA. CastroAR deVivar1997A dirhamnopyranoside from Psacalium megaphyllum.Phytochem4612971300
- 39. Rice-Evans CA, Miller NJ, Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med 20: 933–956.CA Rice-EvansNJ MillerG. Paganga1996Structure-antioxidant activity relationships of flavonoids and phenolic acids.Free Rad Biol Med20933956
- 40. Heim KE, Tagliaferro AR, Bobilya DJ (2002) Flavonoid antioxidants: Chemistry, metabolism, and structure-activity relationships. J Nutr Biochem 13: 572–584.KE HeimAR TagliaferroDJ Bobilya2002Flavonoid antioxidants: Chemistry, metabolism, and structure-activity relationships.J Nutr Biochem13572584
- 41. Cotelle N (2001) Role of flavonoids in oxidative stress. Cur Top Med Chem 1: 569–590.N. Cotelle2001Role of flavonoids in oxidative stress.Cur Top Med Chem1569590
- 42. Enroth C, Eger BT, Okamoto K, Nishino T, Nishino T, et al. (2000) Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci U S A 97: 10723–10728.C. EnrothBT EgerK. OkamotoT. NishinoT. Nishino2000Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion.Proc Natl Acad Sci U S A971072310728
- 43. Eger BT, Okamoto K, Enroth C, Sato M, Nishino T, et al. (2000) Purification, crystallization and preliminary X-ray diffraction studies of xanthine dehydrogenase and xanthine oxidase isolated from bovine milk. Acta Crystallogr D Biol Crystallogr 56: 1656–1658.BT EgerK. OkamotoC. EnrothM. SatoT. Nishino2000Purification, crystallization and preliminary X-ray diffraction studies of xanthine dehydrogenase and xanthine oxidase isolated from bovine milk.Acta Crystallogr D Biol Crystallogr5616561658
- 44. Vermeris W, Nicholson R (2006) W. VermerisR. Nicholson2006In Phenolic Compound Biochemistry, Springer. In Phenolic Compound Biochemistry, Springer.
- 45. Van Hoorn DE, Nijveldt RJ, Van Leeuwen PA, Hofman Z, M'Rabet L, et al. (2002) Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharm 451: 111–118.DE Van HoornRJ NijveldtPA Van LeeuwenZ. HofmanL. M'Rabet2002Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids.Eur J Pharm451111118